Monocytic HLA-DR expression in intensive care patients: Interest for prognosis and secondary infection prediction

Critical Care Medicine

Volumn 37, Issue 10, 2009, Pages 2746-2752

  Lukaszewicz, Anne Claire ^a   Grienay, Marion ^a   Resche Rigon, Matthieu ^b   Pirracchio, Romain ^a   Faivre, Valérie ^a   Boval, Bernadette ^a   Payen, Didier ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Immunocompetence; Immunoparalysis; Marker; Nosocomial infection

Indexed keywords

BIOLOGICAL MARKER; HLA DR ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HOSPITAL DISCHARGE; HUMAN; IMMUNE FUNCTION TEST; INCIDENCE; INFECTION RISK; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SECONDARY INFECTION; SEPSIS; TEACHING HOSPITAL; TERTIARY HEALTH CARE;

EID: 70349653291     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181ab858a     Document Type: Article

References (45)

1. Medzhitov R, Janeway C Jr: Innate immunity. N Engl J Med 2000; 343:338-344
2. Docke WD, Hoflich C, Davis KA, et al: Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: A multicenter standardized study. Clin Chem 2005; 51:2341-2347
3. Flohe S, Lendemans S, Schade FU, et al: Influence of surgical intervention in the immune response of severely injured patients. Intensive Care Med 2004; 30:96-102
4. Caille V, Chiche JD, Nciri N, et al: Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock. Shock 2004; 22:521-526
5. Satoh A, Miura T, Satoh K, et al: Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Pancreas 2002; 25:245-250
6. Richter A, Nebe T, Wendl K, et al: HLA-DR expression in acute pancreatitis. Eur J Surg 1999; 165:947-951
7. Le Tulzo Y, Pangault C, Amiot L, et al: Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med 2004; 169:1144-1151
8. Monneret G, Lepape A, Voirin N, et al: Persisting low monocyte human leukocyte anti- gen-DR expression predicts mortality in septic shock. Intensive Care Med 2006; 32: 1175-1183
9. Alberti C, Brun-Buisson C, Burchardi H, et al: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28:108-121
10. Pronovost P, Needham D, Berenholtz S, et al: An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-2732
11. Venet F, Tissot S, Debard AL, et al: Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med 2007; 35:1910-1917
12. Perry SE, Mostafa SM, Wenstone R, et al: Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis? Intensive Care Med 2003; 29:1245-1252
13. Fumeaux T, Pugin J: Is the measurement of monocytes HLA-DR expression useful in patients with sepsis? Intensive Care Med 2006; 32:1106-1108
14. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
15. Vincent JL, Moreno R, Takala J, et al: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22:707-710
16. Lekkou A, Karakantza M, Mouzaki A, et al: Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004; 11: 161-167
17. Monneret G, Finck ME, Venet F, et al: The anti-inflammatory response dominates after septic shock: Association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 2004; 95: 193-198
18. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
19. Gaynes RP, Horan TC: Surveillance of nosocomial infections. In: Mayhall CG (Ed). Hospital Epidemiology and Infection Control. Third Edition. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 1285-1318
20. Le Cessie S, van Houwelingen JC: A goodness- of-fit test for binary regression models, based on smoothing methods. Biometrics 1991; 47:1267-1282
21. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Statist Assoc 1999; 94:496-509
22. Resche-Rigon M, Azoulay E, Chevret S: Evaluating mortality in intensive care units: Contribution of competing risks analyses. Crit Care 2006; 10:R5
23. Sprung CL, Annane D, Keh D, et al: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
24. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
25. Yadavalli GK, Auletta JJ, Gould MP, et al: Deactivation of the innate cellular immune response following endotoxic and surgical injury. Exp Mol Pathol 2001; 71:209-221
26. Belikova I, Lukaszewicz AC, Faivre V, et al: Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med 2007; 35:2702-2708
27. Calvano SE, Xiao W, Richards DR, et al: A network-based analysis of systemic inflammation in humans. Nature 2005; 437: 1032-1037
28. Pachot A, Monneret G, Brion A, et al: Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients. Crit Care Med 2005; 33: 31-38; discussion 236-237
29. Payen D, Lukaszewicz AC, Belikova I, et al: Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Med 2008; 34:1371-1376
30. Marie C, Losser MR, Fitting C, et al: Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Am J Respir Crit Care Med 1997; 156: 1515-1522
31. Pangault C, Le Tulzo Y, Tattevin P, et al: Down-modulation of granulocyte macrophage- colony stimulating factor receptor on monocytes during human septic shock. Crit Care Med 2006; 34:1193-1201
32. Williams MA, Withington S, Newland AC, et al: Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colonystimulating factor ex vivo. J Infect Dis 1998; 178:1421-1433
33. Asadullah K, Woiciechowsky C, Docke WD, et al: Immunodepression following neurosurgical procedures. Crit Care Med 1995; 23: 1976-1983
34. Tracey KJ: Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007; 117:289-296
35. Woiciechowsky C, Asadullah K, Nestler D, et al: Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 1998; 4:808-813
36. Ferreira FL, Bota DP, Bross A, et al: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286:1754-1758
37. Docke WD, Randow F, Syrbe U, et al: Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997; 3:678-681
38. Wolk K, Docke WD, von Baehr V, et al: Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000; 96:218-223
39. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001; 163:316-321
40. Hynninen M, Pettila V, Takkunen O, et al: Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock 2003; 20:1-4
41. Muehlstedt SG, Lyte M, Rodriguez JL: Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia. Shock 2002; 17:443-450
42. Allen ML, Peters MJ, Goldman A, et al: Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 2002; 30:1140-1145
43. Keh D, Boehnke T, Weber-Cartens S, et al: Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003; 167:512-520
44. Payen D, Faivre V, Lukaszewicz AC, et al: Assessment of immunological status in the critically ill. Minerva Anestesiol 2000; 66: 757-763
45. Nierhaus A, Montag B, Timmler N, et al: Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony- stimulating factor in patients with severe sepsis. Intensive Care Med 2003; 29: 646-651